INBX (Inhibrx Biosciences) Market Cap : $204.40 Mil (As of Mar. 17, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Inhibrx Biosciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Inhibrx Biosciences's share price for the quarter that ended in Sep. 2024 was $15.66. Inhibrx Biosciences's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 14.48 Mil. Therefore, Inhibrx Biosciences's market cap for the quarter that ended in Sep. 2024 was $226.69 Mil.

Inhibrx Biosciences's quarterly market cap increased from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($205.12 Mil) and increased from Jun. 2024 ($205.12 Mil) to Sep. 2024 ($226.69 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Inhibrx Biosciences's Enterprise Value for Today is $9.90 Mil.

Inhibrx Biosciences Market Cap Historical Data

The historical data trend for Inhibrx Biosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhibrx Biosciences Market Cap Chart

Inhibrx Biosciences Annual Data

Trend

Dec22

Dec23

Market Cap

Inhibrx Biosciences Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Market Cap	Get a 7-Day Free Trial			-	-	-	205.12	226.69

Competitive Comparison of Inhibrx Biosciences's Market Cap

For the Biotechnology subindustry, Inhibrx Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inhibrx Biosciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inhibrx Biosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Inhibrx Biosciences's Market Cap falls into.

Inhibrx Biosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Inhibrx Biosciences's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$0	*	14.241
	=	$0.00

Inhibrx Biosciences's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$15.66	*	14.476
	=	$226.69

Inhibrx Biosciences (NAS:INBX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Inhibrx Biosciences Market Cap Related Terms

Thank you for viewing the detailed overview of Inhibrx Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Inhibrx Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inhibrx Biosciences Inc (NAS:INBX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

11025 N. Torrey Pines Road, Suite 140, La Jolla, CA, USA, 92037

Website

https://www.inhibrx.com

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.